锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01951 锦欣生殖

清明节翌日休市 04-02 16:08:21

2.510

+0.020

+0.80%

最高2.520	最低2.460	成交量2,315万
今开2.490	昨收2.490	日振幅2.41%
总市值68.90亿	流通市值68.90亿	总股本27.45亿
成交额5,768万	换手率0.84%	流通股本27.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01951","market":"HK","secType":"STK","nameCN":"锦欣生殖","latestPrice":2.51,"timestamp":1775117301004,"preClose":2.49,"halted":0,"volume":23145500,"delay":0,"changeRate":0.008032128514056052,"floatShares":2745000000,"shares":2745000000,"eps":-0.4095131203561463,"marketStatus":"清明节翌日休市","change":0.02,"latestTime":"04-02 16:08:21","open":2.49,"high":2.52,"low":2.46,"amount":57683370,"amplitude":0.024096,"askPrice":2.51,"askSize":616500,"bidPrice":2.5,"bidSize":142500,"shortable":3,"etf":0,"ttmEps":-0.4095131203561463,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775611800000},"marketStatusCode":7,"adr":0,"listingDate":1561392000000,"exchange":"SEHK","adjPreClose":2.49,"dividendRate":0.016698,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":0.766001456179113,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01951","defaultTab":"news","newsList":[{"id":"1164959860","title":"锦欣生殖：3月31日回购195.50万股，耗资约462.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164959860","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164959860?lang=zh_cn&edition=full","pubTime":"2026-03-31 22:11","pubTimestamp":1774966318,"startTime":"0","endTime":"0","summary":"锦欣生殖(01951)于2026年3月31日发布公告，披露当日于香港联交所场内回购普通股195.50万股，每股回购价介乎2.35港元至2.37港元，涉资约462.49万港元。公司已发行股本及库藏股数量截至当日分别维持在约27.45亿股及1300万股。\n根据公告，公司获准于2025年6月26日通过的购回授权最多可回购约2.74亿股，至今已依据该授权累计购回约4596.80万股，占授权通过当日已发行股份(不含库藏股)的1.6748%。公司确认已遵守香港联交所证券上市规则及相关法例。公告由董事董阳签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623594306","title":"锦欣生殖（1951.HK）：拐点确立，从修复走向兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2623594306","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623594306?lang=zh_cn&edition=full","pubTime":"2026-03-31 15:12","pubTimestamp":1774941159,"startTime":"0","endTime":"0","summary":"对于锦欣生殖而言，2025年是修复之年，而2026年，则是其由修复走向兑现，重新定义行业价值标杆的启航之年。","market":"hk","thumbnail":"https://img2.gelonghui.com/b17e2-41d553c2-0d61-48e5-8fc0-0317e77cb1fa.jpg?guru_height=720&guru_width=1280&guru_size=154189","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/b17e2-41d553c2-0d61-48e5-8fc0-0317e77cb1fa.jpg?guru_height=720&guru_width=1280&guru_size=154189"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4251611","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1219","01951","BK1583","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623308546","title":"【券商聚焦】华泰证券维持锦欣生殖(01951)“买入”评级 看好新院区与海外业务驱动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2623308546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623308546?lang=zh_cn&edition=full","pubTime":"2026-03-31 13:51","pubTimestamp":1774936275,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券发布研报指，锦欣生殖 的核心投资逻辑在于深圳新院区产能释放与海外业务受益于商保法案执行，将共同驱动公司周期数增长与盈利能力改善，预计2026年收入恢复正增长，经调整净利润较2025年有明显提升。报告指出，锦欣生殖2025年收入为26.49亿元，同比下滑5.8%，经调整净利润为2.09亿元，同比下滑49.7%。维持“买入”评级。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/MzhhOTAyYTdjZDRiNjM5MzViNDA1NmM1MGJjYTk1ODE0Mjk0NzY1Nzk3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MzhhOTAyYTdjZDRiNjM5MzViNDA1NmM1MGJjYTk1ODE0Mjk0NzY1Nzk3.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977850","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623376489","title":"中金：维持锦欣生殖(01951)“跑赢行业”评级 目标价3.50港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623376489","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623376489?lang=zh_cn&edition=full","pubTime":"2026-03-31 09:41","pubTimestamp":1774921265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持锦欣生殖26-27年经调整净利润预测2.76/3.57亿元。维持“跑赢行业”评级及目标价3.50港元，目标价对应26-27年31.1/23.7倍P/E，较最新收盘价有50.9%上升空间。中金主要观点如下：2025年业绩符合该行预期公司公布25全年业绩：收入26.49亿元，经调整净利润2.09亿元，符合该行预期。公司正积极推进美国业务重组以回笼资金，计划扩大医师网络至40人，公司预计规模效应将在26年集中体现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623479033","title":"锦欣生殖(01951)3月30日斥资192.98万港元回购83.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2623479033","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623479033?lang=zh_cn&edition=full","pubTime":"2026-03-31 00:26","pubTimestamp":1774888009,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖(01951)发布公告，于2026年3月30日斥资192.98万港元回购83.35万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1422399.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1219","01951","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159521624","title":"锦欣生殖：3月30日回购83.35万股，耗资约192.98万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159521624","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159521624?lang=zh_cn&edition=full","pubTime":"2026-03-30 22:41","pubTimestamp":1774881710,"startTime":"0","endTime":"0","summary":"锦欣生殖于2026年3月30日公告，公司当日于香港联交所场内回购833,500股普通股，占已发行股本约0.03%，每股回购价介乎2.30港元至2.33港元，合共涉资约192.98万港元。该批回购股份拟注销但尚未注销。回购授权决议于2025年6月26日获通过，授权总数为274,470,604股，公司至今已在香港联交所或其他证券交易所累计回购44,013,000股，占授权通过当日已发行股本约1.6036%。公司确认，本次回购行为符合香港联合交易所有限公司证券上市规则等相关法例的规定。公告由董事董阳签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113849223","title":"锦欣生殖：3月27日回购约351.75万股，耗资约804.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113849223","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113849223?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:11","pubTimestamp":1774872667,"startTime":"0","endTime":"0","summary":"锦欣生殖（01951）于2026年3月27日披露回购股份事宜。公司当日于香港联交所场内回购约3,517,500股，约占已发行股本0.13%。回购价格介乎每股2.26港元至2.31港元，总金额约8,047,336.50港元。\n根据公告，公司回购授权由股东于2025年6月26日通过，授权总数为274,470,604股。截至该日，公司已累计回购43,179,500股，占购回授权当日公司已发行股本1.5732%。本次回购股份尚未注销，变动后公司已发行股本仍维持在2,744,706,043股，库存股数量为13,000,000股。\n公司表示，回购事宜已遵守上市规则及相关法律法规。公告由董事董阳签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623359357","title":"锦欣生殖2025年财报解读：下半年业绩全面回暖 机构预测2026年、2027年是行业复苏拐点","url":"https://stock-news.laohu8.com/highlight/detail?id=2623359357","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623359357?lang=zh_cn&edition=full","pubTime":"2026-03-29 20:34","pubTimestamp":1774787678,"startTime":"0","endTime":"0","summary":"锦欣生殖（HK01951，股价2.32港元，市值63.68亿港元）发布的2025年财报显示，公司全年营业收入26.49亿元（人民币，下同），经调整EBITDA（息税折旧及摊销前利润）达4.91亿元，取卵周期数为28039个。尽管上半年受海外商誉资产减值拖累，但下半年业绩全面回暖，经调整净利润环比大增54.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603293688039966.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603293688039966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622587340","title":"锦欣生殖(01951.HK)3月27日耗资804.7万港元回购351.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622587340","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622587340?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:57","pubTimestamp":1774623422,"startTime":"0","endTime":"0","summary":"格隆汇3月27日丨锦欣生殖(01951.HK)公告，3月27日耗资804.7万港元回购351.8万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260327/32106493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1219","BK1583","BK1597","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173661507","title":"锦欣生殖3月27日回购351.75万股，耗资约804.73万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173661507","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173661507?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:46","pubTimestamp":1774619169,"startTime":"0","endTime":"0","summary":"锦欣生殖医疗集团有限公司于2026年3月27日公告称，公司当日于香港联交所场内回购3,517,500股普通股，约占已发行股本的0.13%。回购价格介乎每股2.26港元至2.31港元，总耗资约8,047,336.5港元。根据公告，此次回购所涉股份将拟注销处理，完成后公司已发行股本仍为2,744,706,043股，库存股份则保持13,000,000股。公司于2025年6月26日通过购回授权，总数为274,470,604股，截至本次回购后已合计回购43,179,500股。公司强调，此次回购符合香港联交所《上市规则》等相关规定。上述公告由董事董阳签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622815363","title":"辅助生殖提供商锦欣生殖发布年报：全年营收26.49亿元， 取卵周期数2.8万例","url":"https://stock-news.laohu8.com/highlight/detail?id=2622815363","media":"新浪科技","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622815363?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:27","pubTimestamp":1774574820,"startTime":"0","endTime":"0","summary":"辅助生殖一体化服务提供商锦欣生殖发布2025年财报，财报显示25年营业收入26.49亿元、取卵周期数28039例。值得注意的是，锦欣生殖2025年上下半年业绩呈现“冰火两重天”，以“取卵周期数”、“管理收入”、“经调EBITDA”、“经净利润”四大指标来看，2025年下半年全面回暖，均实现环比较大增长。　　报告显示，尽管国内出生人口整体呈下降趋势，但辅助生殖渗透率持续攀升，从2018年的7.0%提升至2025年的10.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/tob/2026-03-27/doc-inhskrwe2287795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622629278","title":"锦欣生殖宣布未来三年股东回报规划：约占经调整EBITDA50%-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622629278","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622629278?lang=zh_cn&edition=full","pubTime":"2026-03-26 23:57","pubTimestamp":1774540623,"startTime":"0","endTime":"0","summary":"中国最大的试管婴儿医疗服务提供商锦欣生殖3月26日发布公告称，参考其经调整自由现金流，将通过股息分派及股份回购等方式，启动为其三年的股东回报计划，实现总额相当于相关财政年度经调整EBITDA之50%至80%的股东总回报。分析人士认为，该股东回来方式“诚意满满”，显示了公司盈利能力的强大信心和长期主义。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260326/32102691.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","01951","BK1219","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622864200","title":"锦欣生殖(01951)2025年实现经调整纯利约2.09亿元 末期股息每股4.18港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=2622864200","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622864200?lang=zh_cn&edition=full","pubTime":"2026-03-26 23:46","pubTimestamp":1774539984,"startTime":"0","endTime":"0","summary":"智通财经APP讯，锦欣生殖 公布2025年业绩，收益约为26.49亿元，毛利约8.87亿元，经调整纯利约2.09亿元，拟派末期股息每股4.18港仙。此外，IUI患者数量由截至2024年12月31日止年度的660人增加至截至2025年12月31日止年度的1,947人。于报告期内，成都业务的治疗周期总数持续增加，总治疗周期数增长10.1%。深圳新院区已于2026年2月完成搬家并正式运营，并在前两月已实现同比18%的业务量增长。2025年，其综合平均售价较2024年上升了11.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1597","VIG","BK4588","01951","BK4585","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138428214","title":"锦欣生殖将于股东大会批准后派发末期股息每股0.04元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138428214","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138428214?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:52","pubTimestamp":1774536767,"startTime":"0","endTime":"0","summary":"锦欣生殖3月26日发布公告，董事会决议宣派截至2025年12月31日止年度末期股息，合计人民币1亿元，相当于每股人民币3.70分，该计划尚待股东大会批准后派付。根据公告，此次派息金额约占2025年度非国际财务报告准则经调整EBITDA的20%。同时，公司宣布未来三年将参考常态自由现金流，力争实现相当于非国际财务报告准则经调整EBITDA 50%至80%的年度股东回报。此外，董事会已决议自公告日起十二个月内公开市场回购股份，最高金额为人民币3亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102749958","title":"锦欣生殖(01951)将于2026年7月28日派发末期股息每股0.0418港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1102749958","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102749958?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:52","pubTimestamp":1774536750,"startTime":"0","endTime":"0","summary":"锦欣生殖公告，截至2025年12月31日止年度将派发末期股息，每股0.0418港元，股东批准日期为2026年6月25日。以下为主要派息安排：\n股息分派要点：  \n1. 股息性质：末期股息（普通股息），每股0.0418港元。  \n2. 除净日：2026年6月29日。  \n3. 截止过户时间：2026年6月30日16:30，为符合获派股息需要在此之前递交股份过户文件。  \n4. 暂停办理过户：2026年7月2日至2026年7月7日。  \n5. 记录日期：2026年7月7日。  \n6. 派发日期：2026年7月28日。\n公司表示股息派发将按上述日程进行，敬请相关投资者留意。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621301774","title":"沙利文预计2030年中国辅助生殖市场规模增至630亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621301774","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621301774?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:38","pubTimestamp":1774258721,"startTime":"0","endTime":"0","summary":"国际咨询机构弗若斯特沙利文（下称“沙利文”）最新研究报告认为，供需共振有望推动中国辅助生殖行业逐步回暖。这份《2026年中国辅助生殖行业发展现状及未来趋势白皮书》（下称“报告”）提出，在高龄不孕比例上升及治疗渗透率提升驱动下，中国辅助生殖市场处于需求释放阶段，预计市场规模将由2020年的235亿元增长至2030年的630亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603233681044252.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603233681044252.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1597","01951","BK1583","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621721029","title":"锦欣生殖(01951)南方总部落子深圳 “一院二中心”服务大湾区辐射东南亚","url":"https://stock-news.laohu8.com/highlight/detail?id=2621721029","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621721029?lang=zh_cn&edition=full","pubTime":"2026-03-23 13:20","pubTimestamp":1774243214,"startTime":"0","endTime":"0","summary":"锦欣生殖相关负责人表示，以新院区为核心，南方总部将协同香港感恩医疗中心、锦欣医疗科技创新中心的服务和科研优势，引入东南亚、欧美领先的行业技术、学术、管理资源，面向大湾区、辐射东南亚及国际市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","159983","BK1597","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619114625","title":"科研启航，实战先行！锦欣生殖8位精英圆满完成特训营第一阶段课程","url":"https://stock-news.laohu8.com/highlight/detail?id=2619114625","media":"JXR锦欣生殖","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619114625?lang=zh_cn&edition=full","pubTime":"2026-03-13 10:22","pubTimestamp":1773368520,"startTime":"0","endTime":"0","summary":"锦欣生殖科研赋能临床实践迈出坚实第一步。锦欣生殖的8位学员已将培训热情转化为行动力，他们不仅是各院区一线临床工作的中坚力量，更是未来学科发展的火种。让我们共同见证锦欣生殖人才梯队的又一次华丽蜕变，用科研硬实力为患者提供更专业的医疗服务！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzUwOTg5MDE0NA==&mid=2247502583&idx=3&sn=fcb2421227f066519e96d820d577955d&chksm=f909d1f8ce7e58ee6e741b7870d85be5b8af0da43c83569c514e975e72fcfb8e030a37169134#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK1597","BK1219","01951","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618136002","title":"每日卖空追踪 | 锦欣生殖 03月12日卖空量成交390.6万股，卖空比例为8.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618136002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618136002?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304227,"startTime":"0","endTime":"0","summary":"锦欣生殖北京时间03月12日，跌4.15%，卖空量成交390.6万股，较上一交易日增加25.47%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163331a6ba50c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163331a6ba50c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01951","BK1597","BK1219","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618136012","title":"锦欣生殖03月12日遭主力抛售933.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618136012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618136012?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:15","pubTimestamp":1773303346,"startTime":"0","endTime":"0","summary":"03月12日, 锦欣生殖股价跌4.15%，报收2.31元，成交金额1.1亿元，换手率1.70%，振幅4.56%，量比2.01。锦欣生殖今日主力资金净流出933.2万元，连续4日净流出，上一交易日主力净流出793.4万元。该股近5个交易日下跌4.56%，主力资金累计净流出704.6万元；近20日主力资金累计净流出3221.2万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161928a46366c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312161928a46366c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1219","BK1597","01951"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jxr-fertility.com","stockEarnings":[{"period":"1week","weight":0.1057},{"period":"1month","weight":0.0591},{"period":"3month","weight":0.0458},{"period":"6month","weight":-0.1193},{"period":"1year","weight":-0.1929},{"period":"ytd","weight":0.0546}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0253},{"period":"3month","weight":-0.0464},{"period":"6month","weight":-0.0746},{"period":"1year","weight":0.0825},{"period":"ytd","weight":-0.0201}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"锦欣生殖医疗集团有限公司是一家投资控股公司，主要提供试管受精（IVF）服务。该公司通过其子公司主要提供辅助生殖服务、管理服务、流动手术中心设施服务、辅助医疗服务、妇产儿科医疗服务，以及从事医疗消耗品及设备销售业务。该公司主要在中国及美国提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.075891},{"month":2,"riseRate":0.714286,"avgChangeRate":0.046911},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.082521},{"month":4,"riseRate":0.571429,"avgChangeRate":0.038929},{"month":5,"riseRate":0.666667,"avgChangeRate":0.054794},{"month":6,"riseRate":0.666667,"avgChangeRate":0.034942},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.041695},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.091907},{"month":9,"riseRate":0.285714,"avgChangeRate":0.03785},{"month":10,"riseRate":0.428571,"avgChangeRate":0.006103},{"month":11,"riseRate":0.285714,"avgChangeRate":0.086782},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.025172}],"exchange":"SEHK","name":"锦欣生殖","nameEN":"JXR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"锦欣生殖,01951,锦欣生殖股票,锦欣生殖股票老虎,锦欣生殖股票老虎国际,锦欣生殖行情,锦欣生殖股票行情,锦欣生殖股价,锦欣生殖股市,锦欣生殖股票价格,锦欣生殖股票交易,锦欣生殖股票购买,锦欣生殖股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"锦欣生殖(01951)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供锦欣生殖(01951)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}